Ingmar van Hengel, PhD

Director of Business Development | Cryptobiotix

Ghent, Flemish Region, Belgium

About

Experienced scientist and biomedical engineer with expertise in microbiology, medical devices, orthopedics, regenerative medicine, immuno-oncology, microbiome, biomaterials, 3D printing and business development. Awarded multiple research awards, 1st author of 9 scientific publications. PhD on Additively manufactured multifunctional implants at Delft University of Technology. MSc in Biomedical Sciences at Leiden University & Biomedical Engineering at Delft University of Technology. Research exchanges at German Research Cancer Center (DKFZ) in Heidelberg, Karolinska Institute in Stockholm and Tissue Biology Research Unit (TBRU) in Zurich English, Dutch and German speaking.

Experience

  • Cryptobiotix (3 yrs 4 mos)
    • Director of Business Development
      Jan 2025 - Present · 1 yr 6 mos

    • Business Development Manager
      Mar 2023 - Dec 2024 · 1 yr 10 mos

  • Director of Business Intelligence at Alira Health
    Jan 2022 - Jan 2023 · 1 yr 1 mo

  • Business Analyst at Patchai
    May 2021 - Dec 2021 · 8 mos

  • Researcher Phd Candidate at Technische Universiteit Delft
    Jan 2017 - Mar 2021 · 4 yrs 3 mos

  • Masterthesis Biomedical Engineering at TU Delft
    Jan 2016 - Aug 2016 · 8 mos

    3D printing antimicrobial implants Grade: 9